Domestic and international surrogacy laws: Implications for cancer survivors

Kiran Sreenivas, Lisa Campo-Engelstein

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Much of the focus in the new field of oncofertility has been on preserving cancer patients' fertility prior to treatment that is likely to diminish their fertility or render them sterile. Less attention, however, has been paid to the logistics of using frozen eggs, embryos, or ovarian tissue following cancer treatment. It is usually assumed that, following some manipulation, the frozen eggs, embryos, or ovarian tissue will be transferred back into the women's bodies via assisted reproductive technology (ART) so that they can become pregnant. Some women, however, cannot utilize this technology because their cancer treatment has left them unable to gestate. If these women desire biological children and have banked eggs, embryos, or ovarian tissue, then the only option available to them is surrogacy.

Original languageEnglish (US)
Title of host publicationOncofertility
Subtitle of host publicationEthical, Legal, Social, and Medical Perspectives
Editorsteresa Woodruff, Sarah Rodriguez, Lisa Campo-Engelstein, Laurie Zoloth
Pages135-152
Number of pages18
DOIs
StatePublished - 2010

Publication series

NameCancer Treatment and Research
Volume156
ISSN (Print)0927-3042

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Domestic and international surrogacy laws: Implications for cancer survivors'. Together they form a unique fingerprint.

  • Cite this

    Sreenivas, K., & Campo-Engelstein, L. (2010). Domestic and international surrogacy laws: Implications for cancer survivors. In T. Woodruff, S. Rodriguez, L. Campo-Engelstein, & L. Zoloth (Eds.), Oncofertility: Ethical, Legal, Social, and Medical Perspectives (pp. 135-152). (Cancer Treatment and Research; Vol. 156). https://doi.org/10.1007/978-1-4419-6518-9_10